Simple Rapid Near-Patient Diagnostics for Tuberculosis Remain Elusive—Is a “Treat-to-Test” Strategy More Realistic?

PLoS Pathogens

Oleg A. Mayboroda¹  Richard M. Anthony²  Alice L. den Hertog²  Paul R. Klatser² 

[1] Biomolecular Mass Spectrometry Unit, Leiden University Medical Centre (LUMC), Leiden, The Netherlands;KIT Biomedical Research, Royal Tropical Institute, Amsterdam, The Netherlands

关键词: Tuberculosis;    Biomarkers;    Mycobacterium tuberculosis;    Tuberculosis diagnosis;    management;    Antibodies;    Tuberculosis drug discovery;    Antibody response;    Diagnostic medicine;   

DOI  :  10.1371/journal.ppat.1002207

学科分类：生物科学（综合）

来源: Public Library of Science

【 授权许可】

CC BY